Bank of America’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-47,300
| Closed | -$3.56M | – | 7489 |
|
2022
Q2 | $3.56M | Sell |
47,300
-145,473
| -75% | -$10.9M | ﹤0.01% | 3231 |
|
2022
Q1 | $5.18M | Buy |
192,773
+23,232
| +14% | +$624K | ﹤0.01% | 3115 |
|
2021
Q4 | $8.09M | Buy |
169,541
+16,021
| +10% | +$764K | ﹤0.01% | 2708 |
|
2021
Q3 | $10.2M | Buy |
153,520
+20,406
| +15% | +$1.36M | ﹤0.01% | 2463 |
|
2021
Q2 | $10.4M | Buy |
133,114
+66,976
| +101% | +$5.22M | ﹤0.01% | 2439 |
|
2021
Q1 | $6.26M | Buy |
66,138
+9,122
| +16% | +$863K | ﹤0.01% | 2810 |
|
2020
Q4 | $6.95M | Sell |
57,016
-1,568
| -3% | -$191K | ﹤0.01% | 2469 |
|
2020
Q3 | $5.12M | Buy |
58,584
+3,308
| +6% | +$289K | ﹤0.01% | 2551 |
|
2020
Q2 | $3.57M | Buy |
55,276
+44,471
| +412% | +$2.87M | ﹤0.01% | 2816 |
|
2020
Q1 | $483K | Buy |
10,805
+493
| +5% | +$22K | ﹤0.01% | 4014 |
|
2019
Q4 | $642K | Buy |
10,312
+1,287
| +14% | +$80.1K | ﹤0.01% | 4133 |
|
2019
Q3 | $339K | Buy |
9,025
+6,315
| +233% | +$237K | ﹤0.01% | 4583 |
|
2019
Q2 | $110K | Buy |
+2,710
| New | +$110K | ﹤0.01% | 5201 |
|